new_0222_0567|ATHA|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment|price_next_month|price_second_month
new_0222_0567|ATHA|1|Athira Pharma Inc Total Current Assets (Quarterly) (USD)|Athira Pharma Inc Cash and Short Term Investments (Quarterly) (USD)|Athira Pharma Inc Inventories (Quarterly) (USD)|Athira Pharma Inc Net PP&E (Quarterly) (USD)|Athira Pharma Inc Goodwill and Intangibles (Quarterly) (USD)|Athira Pharma Inc Total Liabilities (Quarterly) (USD)|Athira Pharma Inc Total Current Liabilities (Quarterly) (USD)|Athira Pharma Inc Total Long Term Liabilities (Quarterly) (USD)|Athira Pharma Inc Total Deposits (Quarterly) (USD)|Athira Pharma Inc Book Value (Quarterly) (USD)|Athira Pharma Inc Retained Earnings (Quarterly) (USD)|Athira Pharma Inc Treasury Stock (Quarterly) (USD)|Athira Pharma Inc EV to Revenues|Athira Pharma Inc EV to Earnings|Athira Pharma Inc EV to Free Cash Flow|Athira Pharma Inc EV to Assets (Quarterly)|Athira Pharma Inc PS Ratio|Athira Pharma Inc PE Ratio|Athira Pharma Inc Price to Book Value|Athira Pharma Inc PEG Ratio|Athira Pharma Inc Debt to Equity Ratio|Athira Pharma Inc Dividend Yield|Athira Pharma Inc Shareholder Yield (TTM)|Athira Pharma Inc Percent of Shares Outstanding Short|Athira Pharma Inc Total Receivables (Quarterly) (USD)|Athira Pharma Inc Total Payables (Quarterly) (USD)|Athira Pharma Inc Total Capital Stock (Quarterly) (USD)|Athira Pharma Inc Return on Invested Capital|Athira Pharma Inc Quality Ratio Score|Athira Pharma Inc Momentum Score|Athira Pharma Inc Beta (1Y)|Athira Pharma Inc Sustainable Growth Rate (TTM)|Athira Pharma Inc Institutional Investor Ownership Percentage|Athira Pharma Inc Average Diluted Shares Outstanding (Quarterly)|Athira Pharma Inc Total Employees (Annual)|Athira Pharma Inc EPS Diluted (Quarterly) (USD)|Athira Pharma Inc SG&A Expense (Quarterly) (USD)|Athira Pharma Inc Shares Outstanding|Athira Pharma Inc Repurchase of Capital Stock (Quarterly) (USD)|Athira Pharma Inc Ordinary Shares Number (Quarterly)|Athira Pharma Inc Payout Ratio|Athira Pharma Inc Quick Ratio (Quarterly)|Athira Pharma Inc Normalized Diluted EPS (Quarterly) (USD)|Athira Pharma Inc Stock Buybacks (Quarterly) (USD)|Athira Pharma Inc Effective Tax Rate (TTM)|Athira Pharma Inc Return on Equity|Athira Pharma Inc Net Income (TTM) (USD)|Athira Pharma Inc Revenue (TTM) (USD)|Athira Pharma Inc Dividend Per Share (Quarterly) (USD)|Athira Pharma Inc Revenue (Quarterly) (USD)|Athira Pharma Inc Gross Profit (Quarterly) (USD)|Athira Pharma Inc Pre-Tax Income (Quarterly) (USD)|Athira Pharma Inc Net Income (Quarterly) (USD)|Athira Pharma Inc Net Interest Income (Quarterly) (USD)|Athira Pharma Inc Price (USD)|Athira Pharma Inc Total Return Price (USD)|Athira Pharma Inc Enterprise Value (USD)|Athira Pharma Inc 30-Day Average Daily Volume|Athira Pharma Inc 1 Year Price Returns (Daily)|Athira Pharma Inc Short Interest|Athira Pharma Inc PE Ratio (Forward)|Athira Pharma Inc PE Ratio (Forward 1y)|Athira Pharma Inc PS Ratio (Forward)|Athira Pharma Inc PS Ratio (Forward 1y)|Athira Pharma Inc Quarterly EPS Estimates (USD)|Athira Pharma Inc Quarterly Revenue Estimates (USD)|Athira Pharma Inc Quarterly EPS Surprise|Athira Pharma Inc Quarterly Revenue Surprise|Athira Pharma Inc Quarterly Actual EPS (USD)|Athira Pharma Inc Quarterly Actual Revenue (USD)|Athira Pharma Inc Revenue Estimates for Current Fiscal Year (USD)|Athira Pharma Inc Revenue Estimates for Next Fiscal Year (USD)|Athira Pharma Inc Price Target (USD)|Athira Pharma Inc Consensus Recommendation|Athira Pharma Inc Price Target Num Estimates|Athira Pharma Inc EPS Estimates for Current Fiscal Year (USD)|Athira Pharma Inc EPS Estimates for Next Fiscal Year (USD)|Athira Pharma Inc Research and Development Expense (Quarterly) (USD)|Athira Pharma Inc Reconciled Depreciation (Quarterly) (USD)|Athira Pharma Inc Non-Operating Interest Expense (Quarterly) (USD)|Athira Pharma Inc Land and Improvements (Quarterly) (USD)|Athira Pharma Inc Buildings and Improvements (Quarterly) (USD)|Athira Pharma Inc Other Properties (Quarterly) (USD)|Athira Pharma Inc Machine, Furniture & Equipment (Quarterly) (USD)||
new_0222_0567|ATHA|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
new_0222_0567|ATHA|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0567|ATHA|5|106.5|106.5||106.5||106.5|106.5|106.5||106.5|106.5||||1.44755244755||||1.4469273743|||1.4469273743||15.25|106.5|106.5|106.5|||30.6666666667|30.75||30.5|91.375|184|91.375|91.375|27.8||106.5|||91.375|91.3333333333|||91.4|||||91.375|91.375|91.375|1.4469273743|1.4469273743|1.4469273743|1.44984802432|1.42452830189|15.25|||||91.25|91.3333333333|91.25||91.25|91.25|40.8181818182|49.25|24.45|14.3823529412|24.45|28.7647058824|34.9285714286|91.375|91.3333333333|91.375|||106.5|91.5||
new_0222_0567|ATHA|6|6|6||6||6|6|6||6|6||||286||||358|||358||32|6|6|6|||3|4||14|8|1|8|8|15||6|||8|6|||5|||||8|8|8|358|358|358|329|106|32|||||8|9|4||4|4|11|8|20|34|20|17|14|8|6|8|||6|2||
new_0222_0567|ATHA|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0567|ATHA|201909||||||||||||||||||||||||||||||||||8.6035||-0.1778|0.509||||||-0.1689|||||||||-1.53|-1.53|-0.086||||||||||||||||||||||||1.026||0.098||||||
new_0222_0567|ATHA|201912|2.16|2.056||||21.912|1.273|20.639||-19.723|-21.087||||||||||||||0.007|0.421||||||||8.6035||-0.1132|0.459|||28.8146|||-0.1147|||||||||-0.974|-0.974|-0.103||||||||||||||||||||||||0.658||0.11|||0.069|||
new_0222_0567|ATHA|202003||||||||||||||||||||||||||||||||||8.6035||-0.2098|0.675||||||-0.1581|||||||||-1.805|-1.805|-0.212||||||||||||||||||||||||0.592||0.218||||||
new_0222_0567|ATHA|202006|84.973|83.666||0.017||5.512|5.512|||79.919|-25.337||||||||||||||0.007|4.255|0.002|||||||28.8146|15|-0.0691|0.575|||28.8146|||-0.0869||||-6.301|||||-1.992|-1.992|-0.144||||||||||||||||||||||||1.677||0.148||||||
new_0222_0567|ATHA|202009|232.266|226.272||1.962||8.469|7.554|0.915||259.47|-33.34||||||||2.2117|||||1.5286||3.872|0.003||||||71.0995|7.5645||-1.12|1.567|31.0874||31.0874|||-1.0353|-187.224|||-13.227|||||-8.456|-8.456|0.035|18.46|18.46|347.6014|276221.7||475197|||||-0.4|0.0667|-180|-100|-1.12||0.107||42.5|1.5|4|-1.04|-1.56|5.83|||||1.962||18.06|24.9
new_0222_0567|ATHA|202012|192.337|184.682||3.585||5.281|4.405|0.876||274.282|-41.042||||-38.4837||||4.0566|||||3.1524|1.3|1.158|0.003||||||77.1766|32.4858|22|-0.2373|3.892|32.4858||32.4858|||-0.2373|-21.293|||-19.955|||||-7.702|-7.702|0.078|34.25|34.25|927.9566|257394.0333||1024083|||||-0.51||||||0.057||44.25|1.5|4|-1.59|-1.585|5.187||0.001|||1.017||21.32|22.06
new_0222_0567|ATHA|202103|311.568|304.19||4.324||6.197|4.497|1.7||363.217|-49.908||||-12.5442||||1.882|||||2.507|2.906|1.687|0.004|||||||35.7755||-0.25|3.336|37.1503||37.1503|||-0.25|-97.172|||-27.016|||||-8.866|-8.866|0.084|18.4|18.4|379.3755|355899.6333||931351|||||-0.31||19.3548||-0.25||||43.25|1.5|4|-1.93|-1.85|7.445|0.112||||1.548|0.242|19.68|19.94
new_0222_0567|ATHA|202106|290.497|284.94||4.463||9.415|7.634|1.781||350.709|-63.882||||-2.5782||||1.0877|||||3.2589|2.589|1.166|0.004|||||||37.2146||-0.38|4.613|37.2517||37.2517|||-0.38|0.41|||-38.998|||||-13.974|-13.974|0.074|10.24|10.24|96.5174|2096286.4667||1214010|||||-0.325||-16.9231||-0.38||||41.5|1.5|4|-1.35|-1.83|12.024|0.118||||1.764|0.242|9.61|10.59
new_0222_0567|ATHA|202109|238.992|235.775||4.565||11.094|9.386|1.708||336.237|-79.556||||-2.9848||||1.042|||||3.0413|2.079|0.959|0.004|||2|3.3261||85.5458|37.3124||-0.42|7.119|37.3511||37.3511|||-0.42||||-46.216|||||-15.674|-15.674|0.073|9.38|9.38|114.5783|308291.3667|-49.1874|1135966|||||-0.5||16||-0.42||||39.6667|1.3333|3|-1.68|-1.97|10.707|0.123|0.001|||1.772|0.325|13.07|13.48
new_0222_0567|ATHA|202112|||||||||||||||-6.5363||||1.4474|||||5.4541||||||2|3.19||86.6862||||||||||||||||||||||13.03|13.03|250.9098|349207.9667|-61.9562|2037172|||||-0.475||||||||33.75|1.75|4|-1.515|-2.155||||||||10.3|9.31
new_0222_0567|ATHA|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.46|||||||||||||||||||||
new_0222_0567|ATHA|202206|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.47|||||||||||||||||||||
new_0222_0567|ATHA|202209|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.51|||||||||||||||||||||
new_0222_0567|ATHA|202212||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||